Drug Type Synthetic peptide |
Synonyms- |
Action- |
Mechanism CHMP2B inhibitors(charged multivesicular body protein 2B inhibitors), α-synuclein inhibitors(Synuclein alpha inhibitors) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
License Organization- |
Drug Highest PhaseDiscovery |
First Approval Date- |
Regulation- |
| Indication | Highest Phase | Country/Location | Organization | Date |
|---|---|---|---|---|
| Nervous System Diseases | Discovery | - | 22 Jun 2023 | |
| Nervous System Diseases | Discovery | - | 22 Jun 2023 | |
| Other Diseases | Discovery | - | 22 Jun 2023 | |
| Other Diseases | Discovery | - | 22 Jun 2023 |





